Get the Stockscreener App
11.71
0.34%
-0.04
After Hours:
11.59
-0.12
-1.02%
Certara Inc stock is traded at $11.71, with a volume of 1.96M.
It is down -0.34% in the last 24 hours and down -4.41% over the past month.
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval and increase patient access to medicines. The company has its business presence in the Americas which is also it key revenue generating market, EMEA and Asia Pacific region.
See More
Previous Close:
$11.75
Open:
$11.9
24h Volume:
1.96M
Relative Volume:
1.88
Market Cap:
$1.91B
Revenue:
$360.69M
Net Income/Loss:
$-61.40M
P/E Ratio:
97.58
EPS:
0.12
Net Cash Flow:
$60.93M
1W Performance:
+7.83%
1M Performance:
-4.41%
6M Performance:
-34.51%
1Y Performance:
-19.46%
1-Day Range:
$11.54
$12.05
1-Week Range:
$10.42
$12.05
52-Week Range:
$10.35
$19.87
Certara Inc Stock (CERT) Company Profile
Name
Certara Inc
Sector
Industry
Phone
(415) 237-8272
Address
4 RADNOR CORPORATE CENTER, SUITE 350, RADNOR
Certara Inc Stock (CERT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-10-24 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Apr-04-24 | Initiated | JMP Securities | Mkt Perform |
| Feb-26-24 | Initiated | Leerink Partners | Market Perform |
| Dec-07-23 | Initiated | UBS | Neutral |
| Dec-05-23 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Aug-22-23 | Downgrade | Jefferies | Buy → Hold |
| Aug-10-23 | Downgrade | William Blair | Outperform → Mkt Perform |
| Apr-12-23 | Initiated | Stephens | Overweight |
| Apr-03-23 | Downgrade | Barclays | Overweight → Equal Weight |
| Dec-14-22 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Sep-08-22 | Initiated | Berenberg | Buy |
| Aug-25-22 | Initiated | Credit Suisse | Outperform |
| Jul-01-22 | Initiated | Piper Sandler | Overweight |
| Jan-11-22 | Upgrade | Jefferies | Hold → Buy |
| Aug-05-21 | Resumed | Credit Suisse | Neutral |
| Jul-23-21 | Initiated | Robert W. Baird | Outperform |
| Mar-03-21 | Initiated | Barclays | Overweight |
| Jan-06-21 | Initiated | Morgan Stanley | Equal-Weight |
| Jan-05-21 | Initiated | BofA Securities | Buy |
| Jan-05-21 | Initiated | Credit Suisse | Neutral |
| Jan-05-21 | Initiated | Jefferies | Hold |
| Jan-05-21 | Initiated | William Blair | Outperform |
View All
Certara Inc Stock (CERT) Latest News
Certara Inc (CERT) Stock: A 52-Week Tale of Drops and Gains - The InvestChronicle
Envestnet Asset Management Inc. Has $7.95 Million Holdings in Certara, Inc. (NASDAQ:CERT) - MarketBeat
Certara, Inc. (NASDAQ:CERT) Short Interest Update - MarketBeat
Certara, Inc. (NASDAQ:CERT) Shares Acquired by Sei Investments Co. - MarketBeat
UBS Upgrades Certara (CERT) - MSN
Wall Street SWOT: Certara stock navigates biotech headwinds amid software strength - Investing.com Canada
Beyond The Numbers: 4 Analysts Discuss Certara Stock - Benzinga
Certara stock gains as UBS upgrades to buy (NASDAQ:CERT) - Seeking Alpha
Certara (NASDAQ:CERT) Shares Gap Up to $10.70 - MarketBeat
Wall Street SWOT: Certara stock navigates biotech headwinds amid software strength - Investing.com UK
Certara (NASDAQ:CERT) Rating Increased to Buy at UBS Group - MarketBeat
Certara upgraded to Buy from Neutral at UBS - TipRanks
UBS sees Certara stock growth as biosimulation gains traction - Investing.com India
UBS sees Certara stock growth as biosimulation gains traction - Investing.com
Certara, Inc. (NASDAQ:CERT) is Daventry Group LP's 7th Largest Position - MarketBeat
Certara Inc (CERT)’s Ratio Roundup: Key Metrics for Trailing Twelve Months - The Dwinnex
Examining Certara Inc (CERT) more closely is necessary - US Post News
A significant driver of top-line growth: Certara Inc (CERT) - SETE News
Certara’s Simcyp Consortium Celebrates 25th Anniversary - StockTitan
(CERT) Technical Data - Stock Traders Daily
Kayne Anderson Rudnick Investment Management LLC Has $11.22 Million Position in Certara, Inc. (NASDAQ:CERT) - MarketBeat
Certara, Inc. (NASDAQ:CERT) Receives $17.79 Average Price Target from Brokerages - MarketBeat
Certara, Inc. (NASDAQ:CERT) Shares Sold by Granite Investment Partners LLC - MarketBeat
Certara (NASDAQ:CERT) Seems To Use Debt Quite Sensibly - Simply Wall St
Can you now get a good deal on Certara Inc’s shares? - US Post News
Certara & Ichnos Glenmark Innovation Collaboration Optimizes Dosing Strategy for Potential First-In-Class Cancer Drug - ForexTV.com
Certara & Ichnos Glenmark Innovation Collaboration Optimizes Dosing Strategy for Potential First-In-Class Cancer Drug - StockTitan
Choreo LLC Takes $348,000 Position in Certara, Inc. (NASDAQ:CERT) - Defense World
Oppenheimer Asset Management Inc. Purchases 61,980 Shares of Certara, Inc. (NASDAQ:CERT) - MarketBeat
Certara (NASDAQ:CERT) Shares Up 5% - MarketBeat
It is Poised to be a Bull Market for Certara Inc (CERT) - SETE News
Should You Increase Your Holdings in Certara (CERT)? - Insider Monkey
Should You Increase Your Holdings in Certara (CERT)? - Yahoo Finance
Market Resilience: Certara Inc (CERT) Finishes Weak at 10.70, Down -2.28 - The Dwinnex
Certara: Still Awaiting Consistent Growth (NASDAQ:CERT) - Seeking Alpha
Certara (NASDAQ:CERT) Sees Strong Trading Volume - MarketBeat
Certara, Inc. (NASDAQ:CERT) Shares Sold by William Blair Investment Management LLC - MarketBeat
Certara Inc (CERT) Strikes $10.72: The Risk Seems Worthwhile At This Price - Stocks Register
Market Recap: Certara Inc (CERT)’s Negative Momentum, Closing at 10.72 - The Dwinnex
Certara Inc [CERT] PRESIDENT, CHIEF COMMERCAL OFF makes an insider purchase of 51,224 shares worth 0.58 million. – Knox Daily - Knox Daily
Is Certara Inc (CERT) worth investing in despite its undervalued state? - US Post News
Certara stock hits 52-week low at $10.72 amid market challenges - Investing.com India
Certara stock hits 52-week low at $10.72 amid market challenges - Investing.com
Certara stock hits 52-week low at $10.72 amid market challenges - Investing.com UK
Certara president sells over $578k in company stock - Investing.com
Insider Selling: Certara, Inc. (NASDAQ:CERT) Insider Sells 51,224 Shares of Stock - MarketBeat
Certara (NASDAQ:CERT) Reaches New 1-Year Low at $10.96 - MarketBeat
A look into Certara Inc (CERT)’s deeper side - SETE News
Certara Inc Inc. (CERT) Price Performance: A Technical Analysis Perspective - The InvestChronicle
Computational Toxicology Software Market Show Incredible Growth Soon | Certara, BIOVIA, Zymergen - openPR
The Certara Inc (CERT) had a good session last reading, didn’t it? - US Post News
Certara Inc Stock (CERT) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.31%
0.40%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):